How Technology is Revealing the Big Picture in Pharma

July 24, 2018

The collection and analysis of data generated outside of restricted clinical trials are now critical to pharma companies. Data gathered in the routine delivery of healthcare can be mined to uncover insights into treatment efficacies and outcomes in the real world. Such insights, known as real-world evidence (RWE), benefits teams working across the drug lifecycle by showing how larger, heterogeneous patient populations interact with the healthcare system and respond to medicines.

Spotlight

Verix

Getting timely, focused, and relevant insights is crucial to your success and ability to influence. Verix’s cloud-based suite of analytic applications was developed specifically for Pharma commercial operations. Thousands of daily users from our Fortune 500 clients testify to our outstanding value and service.

OTHER WHITEPAPERS
news image

Pharma R&D Annual Review

whitePaper | March 15, 2022

Successes in 2021 – New active substance drug launches

Read More
news image

THE PHARMACEUTICAL INDUSTRY AND GLOBAL HEALTH

whitePaper | January 31, 2022

COVID-19 is an infectious disease caused by a newly discovered coronavirus, which was first identified in December 2019.

Read More
news image

Market Access Trends in the US, Europe, and Emerging Markets

whitePaper | November 14, 2022

Rising drug spending and increased desire for expenditure controls are consistent themes across the US, Europe, and emerging markets.

Read More
news image

Advancements in Drug Development and Formulation

whitePaper | December 13, 2022

A recent e-symposium presented insights into the latest research and innovative solutions to help shorten timeto-market, reduce development costs, increase yield, and assure quality and pharmacopoeia compliance throughout the drug development process.

Read More
news image

A BLOCKCHAIN TO ENSURE COUNTERFEIT FREE PHARMACEUTICAL SUPPLY CHAIN

whitePaper | February 5, 2022

Essential medicine access is one of the main objectives of healthcare systems in and pharmaceutical supply chains ensure that the right amount of medicine, with acceptable quality, will reach the customers in need

Read More
news image

Using High Throughput SPR to Explore the Full Kinetic and Epitope Diversity of Large Antibody Libraries

whitePaper | February 24, 2023

A new way of thinking and working has evolved for the discovery of therapeutic antibodies. Until recently, large numbers of antibodies were generated, only for a relatively small fraction to be sampled and engineered for further lead generation.

Read More

Spotlight

Verix

Getting timely, focused, and relevant insights is crucial to your success and ability to influence. Verix’s cloud-based suite of analytic applications was developed specifically for Pharma commercial operations. Thousands of daily users from our Fortune 500 clients testify to our outstanding value and service.

Events